SPG11: clinical and genetic features of seven Czech patients and literature review

References

• de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, et al. Hereditary spastic paraplegia: clinical and genetic hallmarks. Cerebellum. 2017;16:525–551.
   PubMed Web of Science ®Google Scholar
• Lo Giudice T, Lombardi F, Santorelli FM, et al. Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol. 2014;261:518–539.
   PubMed Web of Science ®Google Scholar
• Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983;1:1151–1155.
   PubMed Web of Science ®Google Scholar
• Orsucci D, Petrucci L, Ienco EC, et al. Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany. Clin Neurol Neurosurg. 2014;120:14–19.
   PubMed Web of Science ®Google Scholar
• Yoon G, Baskin B, Tarnopolsky M, et al. Autosomal recessive hereditary spastic paraplegia-clinical and genetic characteristics of a well-defined cohort. Neurogenetics. 2013;14:181–188.
   PubMed Web of Science ®Google Scholar
• Chrestian N, Dupre N, Gan-Or Z, et al. Clinical and genetic study of hereditary spastic paraplegia in Canada. Neurol Genet. 2017;3:e122.
   PubMed Web of Science ®Google Scholar
• Kumar KR, Blair NF, Vandebona H, et al. Targeted next generation sequencing in SPAST-negative hereditary spastic paraplegia. J Neurol. 2013;260:2516–2522.
   PubMed Web of Science ®Google Scholar
• Martinez Murillo F, Kobayashi H, Pegoraro E, et al. Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology. 1999;53:50–56.
   PubMed Web of Science ®Google Scholar
• Stevanin G, Santorelli FM, Azzedine H, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet. 2007;39:366–372.
   PubMed Web of Science ®Google Scholar
• Stenson PD, Mort M, Ball EV, et al. The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133:1–9.
   PubMed Web of Science ®Google Scholar
• Perez-Branguli F, Mishra HK, Prots I, et al. Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia. Hum Mol Genet. 2014;23:4859–4874.
   PubMed Web of Science ®Google Scholar
• Hehr U, Bauer P, Winner B, et al. Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. Ann Neurol. 2007;62:656–665.
   PubMed Web of Science ®Google Scholar
• Orlacchio A, Babalini C, Borreca A, et al. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591–598.
   PubMed Web of Science ®Google Scholar
• Montecchiani C, Pedace L, Lo Giudice T, et al. ALS5/SPG11/KIAA1840 mutations cause autosomal recessive axonal Charcot-Marie-Tooth disease. Brain. 2016;139:73–85.
   PubMed Web of Science ®Google Scholar
• Schule R, Wiethoff S, Martus P, et al. Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol. 2016;79:646–658.
   PubMed Web of Science ®Google Scholar
• Zech M, Jech R, Boesch S, et al. Monogenic variants in dystonia: an exome-wide sequencing study. Lancet Neurol. 2020;19:908–918.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405–424.
   PubMed Web of Science ®Google Scholar
• Landrum MJ, Lee JM, Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:D1062–D1067.
   PubMed Web of Science ®Google Scholar
• Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29:308–311.
   PubMed Web of Science ®Google Scholar
• Stevanin G, Azzedine H, Denora P, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain. 2008;131:772–784.
   PubMed Web of Science ®Google Scholar
• Pascual B, De Bot ST, Daniels MR, et al. “Ears of the Lynx” MRI sign is associated with SPG11 and SPG15 hereditary spastic paraplegia. AJNR Am J Neuroradiol. 2019;40:199–203.
   PubMed Web of Science ®Google Scholar
• Gunther S, Elert-Dobkowska E, Soehn AS, et al. High frequency of pathogenic rearrangements in SPG11 and extensive contribution of mutational hotspots and founder alleles. Hum Mutat. 2016;37:703–709.
   PubMed Web of Science ®Google Scholar
• Schneider-Gold C, Dekomien G, Regensburger M, et al. Monozygotic twins with a new compound heterozygous SPG11 mutation and different disease expression. J Neurol Sci. 2017;381:265–268.
   PubMed Web of Science ®Google Scholar
• Paisan-Ruiz C, Nath P, Wood NW, et al. Clinical heterogeneity and genotype-phenotype correlations in hereditary spastic paraplegia because of Spatacsin mutations (SPG11). EUR J Neurol. 2008;15:1065–1070.
   PubMed Web of Science ®Google Scholar
• Crimella C, Arnoldi A, Crippa F, et al. Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum. J Med Genet. 2009;46:345–351.
   PubMed Web of Science ®Google Scholar
• Lynch DS, Koutsis G, Tucci A, et al. Hereditary spastic paraplegia in Greece: characterisation of a previously unexplored population using next-generation sequencing. Eur J Hum Genet. 2016;24:857–863.
   PubMed Web of Science ®Google Scholar
• Puech B, Lacour A, Stevanin G, et al. Kjellin syndrome: long-term neuro-ophthalmologic follow-up and novel mutations in the SPG11 gene. Ophthalmology. 2011;118:564–573.
   PubMed Web of Science ®Google Scholar
• Schule R, Holland-Letz T, Klimpe S, et al. The spastic paraplegia rating scale (SPRS): a reliable and valid measure of disease severity. Neurology. 2006;67:430–434.
   PubMed Web of Science ®Google Scholar
• Paisan-Ruiz C, Dogu O, Yilmaz A, et al. SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia. Neurology. 2008;70:1384–1389.
   PubMed Web of Science ®Google Scholar
• Rubegni A, Storti E, Tessa A, et al. Hereditary spastic paraplegia type 11 with a very late onset. J Neurol. 2015;262:1987–1989.
   PubMed Web of Science ®Google Scholar
• Giannoccaro MP, Liguori R, Arnoldi A, et al. Atypical late-onset hereditary spastic paraplegia with thin corpus callosum due to novel compound heterozygous mutations in the SPG11 gene. J Neurol. 2014;261:1825–1827.
   PubMed Web of Science ®Google Scholar
• Krenn M, Tomschik M, Rath J, et al. Genotype-guided diagnostic reassessment after exome sequencing in neuromuscular disorders: experiences with a two-step approach. Eur J Neurol. 2020;27:51–61.
   PubMed Web of Science ®Google Scholar
• Kara E, Tucci A, Manzoni C, et al. Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain. 2016;139:1904–1918.
   PubMed Web of Science ®Google Scholar
• Dixon-Salazar TJ, Silhavy JL, Udpa N, et al. Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med. 2012;4:138ra178.
   Web of Science ®Google Scholar
• Conceicao Pereira M, Loureiro JL, Pinto-Basto J, et al. Alu elements mediate large SPG11 gene rearrangements: further spatacsin mutations. Genet Med. 2012;14:143–151.
   PubMed Web of Science ®Google Scholar
• Castro-Fernandez C, Arias M, Blanco-Arias P, et al. Targeted NGS meets expert clinical characterization: efficient diagnosis of spastic paraplegia type 11. Appl Transl Genom. 2015;5:33–36.
   PubMedGoogle Scholar
• Meszarosova AU, Seeman P, Jencik J, et al. Two types of recessive hereditary spastic paraplegia in Roma patients in compound heterozygous state; no ethnically prevalent variant found. Neurosci Lett. 2020;721:134800.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Wang MW, Dong EL, et al. Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia. Parkinsonism Relat Disord. 2019;65:256–260.
   PubMed Web of Science ®Google Scholar
• Pensato V, Castellotti B, Gellera C, et al. Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain. 2014;137:1907–1920.
   PubMed Web of Science ®Google Scholar
• Martinuzzi A, Montanaro D, Vavla M, et al. Clinical and paraclinical indicators of motor system impairment in hereditary spastic paraplegia: a pilot study. PLoS One. 2016;11:e0153283.
   PubMed Web of Science ®Google Scholar
• Denora PS, Schlesinger D, Casali C, et al. Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. Hum Mutat. 2009;30:E500–519.
   PubMed Web of Science ®Google Scholar
• Tian X, Wang M, Zhang K, et al. Novel SPG 11 mutations in hereditary spastic paraplegia with thin corpus callosum in a Chinese family. Can J Neurol Sci. 2016;43:833–840.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Quiroga SA, Cordoba M, Gonzalez-Moron D, et al. Neurogenetics in Argentina: diagnostic yield in a personalized research based clinic. Genet Res (Camb). 2015;97:e10.
   PubMed Web of Science ®Google Scholar